14.83 (-%)
As of Nov 21, 2024
Source:
Vtv Therapeutics Inc is a clinical stage pharmaceutical company focused on treating metabolic and inflammatory diseases to minimize their long- term complications and improve the lives of patients. We have an innovative pipeline of first-in-class small molecule clinical and pre-clinical drug candidates. Our lead program is TTP399, an orally administered, small molecule, liver-selective glucokinase activator as an adjunctive therapy to insulin for the treatment of type 1 diabetes.
Country | United States |
Headquarters | high point, north carolina |
Phone Number | 336-841-0300 |
Industry | manufacturing |
CEO | Paul J. Sekhri |
Website | www.vtvtherapeutics.com |